1) ranolazine
雷诺嗪
1.
Optimization of Preparation Technology and In Vitro Dissolution Rate of Ranolazine Sustained Release Tablets;
雷诺嗪缓释片的制备工艺筛选及其体外溶出度考察
2.
Determination of residual solvents in ranolazine by headspace gas chromatography;
顶空气相色谱法测定雷诺嗪中5种有机溶剂残留量
3.
Long-term toxicity of ranolazine in rats;
雷诺嗪对大鼠的长期毒性试验
2) Ranolazine hydrochloride
盐酸雷诺嗪
1.
Determination of ranolazine hydrochloride in rat urine and study on its gender-related metabolism by RP-HPLC;
RP-HPLC法研究不同性别的大鼠尿液中盐酸雷诺嗪及其代谢物的差异
2.
Chemiluminescence determination of ranolazine hydrochloride
化学发光法测定盐酸雷诺嗪含量
3) ranolazine
盐酸雷诺嗪
1.
Gender difference in ranolazine metabolism in rat liver microsomes;
盐酸雷诺嗪在大鼠肝微粒体内代谢的性别差异
2.
Determination of Ranolazine and Its Pharmacokinetics in Dog by LC-MS;
犬血浆中盐酸雷诺嗪LC-MS测定及药物动力学研究
3.
This paper was designed to evaluate the pharmacokinetics and toxicokinetics features of ranolazine in animals, with the dynamic process of toxicity of RNZ described, so as to seek for the toxic target organs and toxic mechanisms, which can also provide foundation for further mechanism study .
生物样品中盐酸雷诺嗪分析方法的建立 目的采用蛋白沉淀法处理血浆和组织样品,建立以劳拉西泮为内标的高效液相-二级质谱法(HPLC/MS/MS)检测盐酸雷诺嗪的体内分析方法。
5) Ranolazine sustained release tablets
雷诺嗪缓释片
1.
Conclusion:Ranolazine sustained release tablets have marked sustained release characters.
方法:采用双周期自身交叉设计,分别单剂量给予犬雷诺嗪缓释片和普通片,用HPLC法测定血浆中的雷诺嗪浓度,用DAS 2。
6) Intermediate of Ranolazine
雷诺嗪中间体
补充资料：雷诺嗪
分子式：C24H33N3O4
分子量：暂无
CAS号：95635-55-5
性质：暂无
制备方法：暂无
用途：抗心绞痛新药。
分子量：暂无
CAS号：95635-55-5
性质：暂无
制备方法：暂无
用途：抗心绞痛新药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条